SCHEMBL4470549

SCHEMBL4470549

COC1=CCC(=C2Oc3cc(O)cc(O)c3C(=O)C2=O)C=C1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HKDC1 Q2TB90 1/20 0.39
PIK3CA P42336 9/20 0.37
MTOR P42345 9/20 0.37
PIK3CG P48736 8/20 0.37
TYR P14679 2/20 0.36
MAOB P27338 5/20 0.36
PNLIP P16233 1/20 0.36
MAOA P21397 3/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
CDK5 Q00535 1/20 0.35
HDAC1 Q13547 1/20 0.35
CDK5R1 Q15078 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4467781 0.81 KDM4E (0.31)
SCHEMBL4739994 0.81 PIK3CA (0.37) PIK3CAMTORPIK3CGTYRMAOB
SCHEMBL3513421 0.76 TYR (0.40) PIK3CAMTORPIK3CGTYRMAOB
SCHEMBL15414521 0.74 TYR (0.40) PIK3CAMTORPIK3CGTYRMAOB
SCHEMBL22055435 0.62 HKDC1 (0.63) HKDC1TYRHDAC6CYP1A1CYP1A2
SCHEMBL23728324 0.60 TYR (0.51) PIK3CAMTORPIK3CGTYRMAOB
SCHEMBL21211447 0.60 MAOB (0.65) PIK3CAMTORPIK3CGTYRMAOB
SCHEMBL5707830 0.59 TYR (0.76) PIK3CAMTORPIK3CGTYRMAOB
SCHEMBL5707825 0.59 TYR (0.76) PIK3CAMTORPIK3CGTYRMAOB
SCHEMBL21211442 0.59 TYR (0.62) PIK3CAMTORPIK3CGTYRMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582675-B2 Flavonoid compound and process for producing the same POKKA CORPORATION (JP) 2009-09-01 US disclosed
US-20060270009-A1 Flavonoid compound and process for producing the same NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2006-11-30 US disclosed
US-7138429-B2 Flavonoid compound and process for producing the same JAPAN SCI. TECH. CORP. (JP) 2006-11-21 US disclosed
EP-1369489-B1 FLAVONOID COMPOUND AND PROCESS FOR PRODUCING THE SAME JAPAN SCIENCE & TECH CORP (JP) 2006-08-23 EP disclosed
US-20040152762-A1 Flavonoid compound and process for producing the same NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2004-08-05 US disclosed
EP-1369489-A1 FLAVONOID COMPOUND AND PROCESS FOR PRODUCING THE SAME Japan Science and Technology Corporation (JP) 2003-12-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152762-A1 Flavonoid compound and process for producing the same ERG28, TFPI, HES1 HKDC1 768/4885PIK3CA 3052/4885MTOR 1818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.